PTLA

Portola Pharmaceuticals, Inc.

PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

221 hedge funds and large institutions have $3.12B invested in Portola Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 97 increasing their positions, 48 reducing their positions, and 25 closing their positions.

2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

221

Holders Change

+15

Holders Change %

+7.28%

% of All Funds

5.52%

Holding in Top 10

Holding in Top 10 Change

-4

Holding in Top 10 Change %

-40%

% of All Funds

0.15%

New

Increased

Reduced

Closed

Calls

$22.9M

Puts

$36.6M

Net Calls

-$13.8M

Net Calls Change

-$24.5M

Top Buyers

1	PHS 1 PFM Health Sciences San Francisco, California	$274M
2	2 Fidelity Investments Boston, Massachusetts	$311M
3	CCM 3 Cadian Capital Management New York	$63M
4	4 Vanguard Group Malvern, Pennsylvania	$283M
5	5 Citadel Advisors Miami, Florida	$56.7M

Top Sellers

1	FCM 1 Farallon Capital Management San Francisco, California	$0
2	CAM 2 Cormorant Asset Management Boston, Massachusetts	$27M
3	3 Balyasny Asset Management Chicago, Illinois	$286K
4	4 Goldman Sachs New York	$23.4M
5	GTC 5 Ghost Tree Capital New York	$0

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 Fidelity Investments Boston, Massachusetts	$311M	5,760,456	+1,971,673	+52%
2	2 Wellington Management Group Boston, Massachusetts	$295M	5,462,947	-184,788	-3%
3	3 Vanguard Group Malvern, Pennsylvania	$283M	5,242,316	+637,409	+14%
4	PHS 4 PFM Health Sciences San Francisco, California	$274M	5,078,146	+2,332,304	+85%
5	5 Temasek Holdings Singapore	$264M	4,883,568	–	–
6	6 BlackRock New York	$238M	4,402,789	+330,823	+8%
7	7 State Street Boston, Massachusetts	$130M	2,401,005	+315,167	+15%
8	CCM 8 Cadian Capital Management New York	$63M	1,166,743	+840,700	+258%
9	9 Citadel Advisors Miami, Florida	$56.7M	1,048,786	+560,144	+115%
10	10 D.E. Shaw & Co New York	$55.7M	1,030,022	-144,908	-12%
11	11 JPMorgan Chase & Co New York	$40.1M	744,702	+26,544	+4%
12	KCM 12 Kornitzer Capital Management Shawnee Mission, Kansas	$39.3M	727,812	+202,925	+39%
13	FAM 13 Fred Alger Management New York	$39.1M	723,731	+13,029	+2%
14	14 Norges Bank Oslo, Norway	$37.5M	694,537	+81,485	+13%
15	15 Northern Trust Chicago, Illinois	$37.2M	687,985	+51,987	+8%
16	16 Deutsche Bank Frankfurt Am Main Ge, Germany	$33.1M	612,995	-13,803	-2%
17	PC 17 Polar Capital London, United Kingdom	$31.8M	588,200	+250,700	+74%
18	ZCI 18 Zevenbergen Capital Investments Edmonds, Washington	$31.2M	577,565	+125,375	+28%
19	19 Geode Capital Management Boston, Massachusetts	$31.1M	576,301	+87,623	+18%
20	20 Renaissance Technologies New York	$28.6M	528,500	+151,300	+40%
21	SAM 21 Sectoral Asset Management Montreal, Quebec, Canada	$27.4M	506,414	+84,271	+20%
22	CAM 22 Cormorant Asset Management Boston, Massachusetts	$27M	500,000	-400,000	-44%
23	PA 23 Pinnacle Associates New York	$26.6M	492,381	-8,655	-2%
24	PAMU 24 Pictet Asset Management (UK) London, United Kingdom	$25.9M	478,690	-43,547	-8%
25	EA 25 Emerald Advisers Leola, Pennsylvania	$24.5M	453,921	+9,703	+2%

Portola Pharmaceuticals, Inc. PTLA

Top Buyers

Top Sellers

Portola Pharmaceuticals, Inc.

PTLA